Development and Evaluation of a Prediction Model for Ascertaining Rheumatic Heart Disease Status in Administrative Data

被引:10
作者
Bond-Smith, D. [1 ]
Seth, R. [1 ]
de Klerk, N. [1 ,2 ]
Nedkoff, L. [1 ]
Anderson, M. [3 ]
Hung, J. [1 ]
Cannon, J. [1 ,2 ]
Griffiths, K. [4 ,5 ]
Katzenellenbogen, J. M. [1 ,2 ]
机构
[1] Univ Western Australia, Sch Populat & Global Hlth, Perth, WA, Australia
[2] Telethon Kids Inst, Perth, WA, Australia
[3] Queensland Hlth, Brisbane, Qld, Australia
[4] Univ New South Wales, Ctr Big Data Res, Sydney, NSW, Australia
[5] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT, Australia
来源
CLINICAL EPIDEMIOLOGY | 2020年 / 12卷
基金
芬兰科学院; 英国医学研究理事会;
关键词
rheumatic heart disease; international classification of diseases; prediction; case ascertainment; acute rheumatic fever; non-rheumatic valvular heart disease; administrative data; validation; discrimination; receiver operating curve; Australia; BURDEN;
D O I
10.2147/CLEP.S241588
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Previous research has raised substantial concerns regarding the validity of the International Statistical Classification of Diseases and Related Health Problems (ICD) codes (ICD-10 105-109) for rheumatic heart disease (RHD) due to likely misclassification of non-rheumatic valvular disease (non-rheumatic VHD) as RHD. There is currently no validated, quantitative approach for reliable case ascertainment of RHD in administrative hospital data. Methods: A comprehensive dataset of validated Australian RHD cases was compiled and linked to inpatient hospital records with an RHD ICD code (2000-2018, n=7555). A prediction model was developed based on a generalized linear mixed model structure considering an extensive range of demographic and clinical variables. It was validated internally using randomly selected cross-validation samples and externally. Conditional optimal probability cutpoints were calculated, maximising discrimination separately for high-risk versus low-risk populations. Results: The proposed model reduced the false-positive rate (FPR) from acute rheumatic fever (ARF) cases misclassified as RHD from 0.59 to 0.27; similarly for non-rheumatic VHD from 0.77 to 0.22. Overall, the model achieved strong discriminant capacity (AUC: 0.93) and maintained a similar robust performance during external validation (AUC: 0.88). It can also be used when only basic demographic and diagnosis data are available. Conclusion: This paper is the first to show that not only misclassification of non-rheumatic VHD but also of ARF as RHD yields substantial FPRs. Both sources of bias can be successfully addressed with the proposed model which provides an effective solution for reliable RHD case ascertainment from hospital data for epidemiological disease monitoring and policy evaluation.
引用
收藏
页码:717 / 730
页数:14
相关论文
共 16 条
  • [1] Adhikari P, 2006, 1351055015 AUSTR BUR
  • [2] [Anonymous], 2016, INT STAT CLASS DIS H
  • [3] [Anonymous], 2018, 1270 0 55 005 AUSTR
  • [4] [Anonymous], 2002, ANAL LONGITUDINAL DA
  • [5] Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS), 2010, NAT CARD SURG DAT ME
  • [6] Acute rheumatic fever and rheumatic heart disease
    Carapetis, Jonathan R.
    Beaton, Andrea
    Cunningham, Madeleine W.
    Guilherme, Luiza
    Karthikeyan, Canesan
    Mayosi, Bongani M.
    Sable, Craig
    Steer, Andrew
    Wilson, Nigel
    Wyber, Rosemary
    Zuhlke, Lies
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2016, 2
  • [7] The global burden of group A streptococcal diseases
    Carapetis, JR
    Steer, AC
    Mulholland, EK
    Weber, M
    [J]. LANCET INFECTIOUS DISEASES, 2005, 5 (11) : 685 - 694
  • [8] Cross-validation for nonlinear mixed effects models
    Colby, Emily
    Bair, Eric
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2013, 40 (02) : 243 - 252
  • [9] Fitz-Gerald JA, 2018, AUSTR EP ASS SCI M
  • [10] The End Rheumatic Heart Disease in Australia Study of Epidemiology (ERASE) Project: data sources, case ascertainment and cohort profile
    Katzenellenbogen, Judith M.
    Bond-Smith, Daniela
    Seth, Rebecca J.
    Dempsey, Karen
    Cannon, Jeffrey
    Nedkoff, Lee
    Sanfilippo, Frank M.
    de Klerk, Nicholas
    Hung, Joe
    Geelhoed, Elizabeth
    Williamson, Daniel
    Wyber, Rosemary
    Ralph, Anna P.
    Bessarab, Dawn
    [J]. CLINICAL EPIDEMIOLOGY, 2019, 11 : 997 - 1010